Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

130.74
Delayed Data
As of 4:00pm ET
 -1.05 / -0.80%
Today’s Change
96.18
Today|||52-Week Range
145.42
+6.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line114.9M99.5M92.4M170.0M
 
 
 
 
 
Depreciation97.8M100.7M90.7M99.0M
 
 
 
 
 
Total Other Cash Flow59.2M91.8M141.4M56.0M
 
 
 
 
 
Funds From Operations318.7M311.6M332.8M324.0M
 
 
 
 
 
Funds From/For Other Operating Expenses74.8M20.2M-49.9M16.0M
 
 
 
 
 
Net Cash Flow - Operating Activities243.9M291.4M382.7M308.0M
 
 
 
 
 
 
InvestingIncrease In Investments-288.6M-162.5M-12.9M-703.0M
 
 
 
 
 
Decrease In Investments24.9M193.3M234.3M283.0M
 
 
 
 
 
Capital Expenditures-66.8M-95.0M-107.0M-75.0M
 
 
 
 
 
Other Investing - Uses-52.0K-1.1M135.0K0.00
 
 
 
 
Other Investing - Sources-82.0K----0.00
 
 
Net Cash Flow Investing-330.7M-65.2M114.6M-495.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.00-200.0M-44.0M
 
 
 
Net Proceeds Stock Sale10.7M7.7M9.2M47.0M
 
 
 
 
 
Common Preferred Redeemed-34.1M-69.3M-30.0M-68.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00----
Other Uses - Financing681.0K552.0K62.7M4.0M
 
 
 
 
 
Net Cash Flow - Financing-24.1M-62.2M-283.5M-69.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.8M457.0K-9.7M3.0M
 
 
 
 
 
 
Net Change In Cash-110.8M164.0M213.8M-256.0M